Compounds > picotamide
Page last updated: 2024-11-02

picotamide and Diabetic Nephropathies

picotamide has been researched along with Diabetic Nephropathies in 1 studies

picotamide: has anticoagulant & fibrinolytic properties; structure

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giustina, A1
Perini, P1
Desenzani, P1
Bossoni, S1
Ianniello, P1
Milani, M1
Davì, G1
Romanelli, G1

Trials

1 trial available for picotamide and Diabetic Nephropathies

ArticleYear
Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
    Diabetes, 1998, Volume: 47, Issue:3

    Topics: Administration, Oral; Albuminuria; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Diabet

1998